Toronto Dominion Bank’s Takeda Pharmaceutical TAK Stock Holding History

Toronto Dominion Bank’s Portfolio TAK Stock Details TAK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-823,200	Closed	-$12.8M	–	2394
2025 Q4	$12.8M	Sell	823,200 -2,181,100	-73%	-$31.2M	0.02%	566
2025 Q3	$44M	Buy	+3,004,300	New	+$44.6M	0.07%	255
2025 Q2	–	Sell	-647,600	Closed	-$9.63M	–	1967
2025 Q1	$9.63M	Buy	647,600 +137,000	+27%	+$1.92M	0.02%	513
2024 Q4	$6.76M	Buy	+510,600	New	+$7.01M	0.01%	637
2021 Q4	–	Sell	-7,630	Closed	-$125K	–	1981
2021 Q3	$125K	Sell	7,630 -80	-1%	-$1.34K	﹤0.01%	1111
2021 Q2	$130K	Sell	7,710 -12,960	-63%	-$221K	﹤0.01%	1096
2021 Q1	$377K	Buy	20,670 +620	+3%	+$11.2K	﹤0.01%	1028
2020 Q4	$364K	Buy	20,050 +3,840	+24%	+$67.4K	﹤0.01%	981
2020 Q3	$290K	Buy	16,210 +1,555	+11%	+$28.3K	﹤0.01%	947
2020 Q2	$264K	Hold	14,655	–	–	﹤0.01%	973
2020 Q1	$225K	Buy	14,655 +650	+5%	+$11.8K	﹤0.01%	943
2019 Q4	$276K	Buy	14,005 +2,000	+17%	+$38.3K	﹤0.01%	987
2019 Q3	$206K	Buy	+12,005	New	+$208K	﹤0.01%	1111
2019 Q2	–	Sell	-9,950	Closed	-$203K	–	1726
2019 Q1	$203K	Buy	+9,950	New	+$200K	﹤0.01%	1168

Other funds holding TAK

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

BIP

Brandes Investment Partners La Jolla, California $14.3B AUM 23.11% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Toronto Dominion Bank's TAK Position: Q1 2026 in Review

Toronto Dominion Bank sold out of Takeda Pharmaceutical (TAK) in Q1 2026, closing a stake of 823,200 shares — an estimated $12.8M sold.

Toronto Dominion Bank first reported a position in TAK in Q1 2019 and held it in 14 quarters. The position peaked at $44M in Q3 2025. 361 funds tracked by Wall St. Rank hold TAK as of Q1 2026.

Toronto Dominion Bank reported no remaining Takeda Pharmaceutical position as of Q1 2026 after selling out during the quarter.
Toronto Dominion Bank sold 823,200 Takeda Pharmaceutical shares in Q1 2026, an estimated $12.8M.
Toronto Dominion Bank first reported a position in Takeda Pharmaceutical in Q1 2019 and held it in 14 quarters.
Toronto Dominion Bank's Takeda Pharmaceutical position peaked at $44M in Q3 2025.
361 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q1 2026.

Based on Toronto Dominion Bank's 13F filing for Q1 2026, filed 15 May 2026.